Early Tracheostomy in Ventilated Stroke Patients
Launched by HEIDELBERG UNIVERSITY · Dec 15, 2010
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
Background: Tracheostomy is a common procedure in critical care patients. Advantages of a short tracheal tube compared to a long orotracheal one are the avoidance of laryngeal lesions and sinusitis, facilitation of nursing care and physiotherapy and the reduction of analgosedatives. The optimal point in time for tracheostomy is still unknown, but it is commonly done not later than 2-3 weeks and after one or several failed extubation trials. Studies in different sets of critical care patients have suggested additional advantages of early tracheostomy: less pneumonias and other complications,...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age \> 18 years
- • informed consent from legal representative
- • non-traumatic cerebrovascular disease
- • Estimated ventilation need for at least 2 weeks
- Exclusion Criteria:
- • age \< 18 years
- • informed consent not obtainable
- • intubated for more than 3 days
- • death within 3 weeks likely
- • severe chronic pulmonary disease
- • severe chronic cardiac disease
- • emergency situation
- • intracranial pressure difficult to control
- • need for a permanent tracheostoma
- • contraindications for dilatative tracheostomy
- • severe coagulopathy
- • severe respiration difficulties
- • intubation/extubation/tube exchange difficulties
About Heidelberg University
Heidelberg University, a prestigious institution located in Germany, is renowned for its commitment to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university fosters a dynamic environment for conducting clinical trials that aim to enhance patient care and improve health outcomes. Leveraging cutting-edge technology and a robust network of healthcare professionals, Heidelberg University is dedicated to exploring novel therapeutic approaches and contributing to the global medical community through rigorous scientific inquiry and ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Heidelberg, , Germany
Patients applied
Trial Officials
Bösel Julian, Dr, MD
Principal Investigator
Department of Neurology, University of Heidelberg
Thorsten Steiner, Prof, MD
Study Chair
Department of Neurology, University of Heidelberg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials